118 related articles for article (PubMed ID: 29761870)
1. Intestinal disposition of quercetin and its phase-II metabolites after oral administration in healthy volunteers.
Chalet C; Rubbens J; Tack J; Duchateau GS; Augustijns P
J Pharm Pharmacol; 2018 Aug; 70(8):1002-1008. PubMed ID: 29761870
[TBL] [Abstract][Full Text] [Related]
2. Intestinal phase-II metabolism of quercetin in HT29 cells, 3D human intestinal tissues and in healthy volunteers: a qualitative comparison using LC-IMS-MS and LC-HRMS.
Chalet C; Hollebrands B; Duchateau GS; Augustijns P
Xenobiotica; 2019 Aug; 49(8):945-952. PubMed ID: 30085847
[TBL] [Abstract][Full Text] [Related]
3. Plasma metabolites of dietary flavonoids after combination meal consumption with onion and tofu in humans.
Nakamura T; Murota K; Kumamoto S; Misumi K; Bando N; Ikushiro S; Takahashi N; Sekido K; Kato Y; Terao J
Mol Nutr Food Res; 2014 Feb; 58(2):310-7. PubMed ID: 24039174
[TBL] [Abstract][Full Text] [Related]
4. Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl- and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions.
Mullen W; Edwards CA; Crozier A
Br J Nutr; 2006 Jul; 96(1):107-16. PubMed ID: 16869998
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of quercetin-7- and quercetin-3-glucuronides by an in vitro hepatic model: the role of human beta-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism.
O'Leary KA; Day AJ; Needs PW; Mellon FA; O'Brien NM; Williamson G
Biochem Pharmacol; 2003 Feb; 65(3):479-91. PubMed ID: 12527341
[TBL] [Abstract][Full Text] [Related]
6. Part of quercetin absorbed in the small intestine is conjugated and further secreted in the intestinal lumen.
Crespy V; Morand C; Manach C; Besson C; Demigne C; Remesy C
Am J Physiol; 1999 Jul; 277(1):G120-6. PubMed ID: 10409158
[TBL] [Abstract][Full Text] [Related]
7. Absorption and disposition of naringenin and quercetin after simultaneous administration via intestinal perfusion in mice.
Orrego-Lagarón N; Martínez-Huélamo M; Quifer-Rada P; Lamuela-Raventos RM; Escribano-Ferrer E
Food Funct; 2016 Sep; 7(9):3880-9. PubMed ID: 27515345
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and modeling of quercetin and metabolites.
Chen X; Yin OQ; Zuo Z; Chow MS
Pharm Res; 2005 Jun; 22(6):892-901. PubMed ID: 15948033
[TBL] [Abstract][Full Text] [Related]
9. Dietary flavonoids as antioxidants in vivo: conjugated metabolites of (-)-epicatechin and quercetin participate in antioxidative defense in blood plasma.
Terao J
J Med Invest; 1999 Aug; 46(3-4):159-68. PubMed ID: 10687310
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer resistance protein (Bcrp1/Abcg2) limits net intestinal uptake of quercetin in rats by facilitating apical efflux of glucuronides.
Sesink AL; Arts IC; de Boer VC; Breedveld P; Schellens JH; Hollman PC; Russel FG
Mol Pharmacol; 2005 Jun; 67(6):1999-2006. PubMed ID: 15749994
[TBL] [Abstract][Full Text] [Related]
11. Use of physiologically based kinetic (PBK) modeling to study interindividual human variation and species differences in plasma concentrations of quercetin and its metabolites.
Boonpawa R; Moradi N; Spenkelink A; Rietjens IM; Punt A
Biochem Pharmacol; 2015 Dec; 98(4):690-702. PubMed ID: 26441251
[TBL] [Abstract][Full Text] [Related]
12. Identification of phase-II metabolites of flavonoids by liquid chromatography-ion-mobility spectrometry-mass spectrometry.
Chalet C; Hollebrands B; Janssen HG; Augustijns P; Duchateau G
Anal Bioanal Chem; 2018 Jan; 410(2):471-482. PubMed ID: 29167932
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous collection of the portal and superior vena cava blood in conscious rats defined that intestinal epithelium is the major site of glucuronidation, but not sulfation and methylation, of quercetin.
Tanaka S; Oyama M; Nishikawa M; Ikushiro S; Hara H
Biosci Biotechnol Biochem; 2018 Dec; 82(12):2118-2129. PubMed ID: 30200823
[TBL] [Abstract][Full Text] [Related]
14. Heteroconjugates of quercetin with 4'-
Tanaka S; Trakooncharoenvit A; Nishikawa M; Ikushiro S; Hara H
Food Funct; 2022 Feb; 13(3):1459-1471. PubMed ID: 35048937
[TBL] [Abstract][Full Text] [Related]
15. Chronic quercetin feeding decreases plasma concentrations of salicylamide phase II metabolites in pigs following oral administration.
Wein S; Cermak R; Wolffram S; Langguth P
Xenobiotica; 2012 May; 42(5):477-82. PubMed ID: 22188411
[TBL] [Abstract][Full Text] [Related]
16. [HPLC-MS analysis of quercetin and its metabolites in portal vein after intragastrical administration of quercetin in rats].
An D; Wu S; Wei J; Yang J
Wei Sheng Yan Jiu; 2009 Jul; 38(4):417-9. PubMed ID: 19689070
[TBL] [Abstract][Full Text] [Related]
17. Carbon dioxide is the major metabolite of quercetin in humans.
Walle T; Walle UK; Halushka PV
J Nutr; 2001 Oct; 131(10):2648-52. PubMed ID: 11584085
[TBL] [Abstract][Full Text] [Related]
18. Lymphatic metabolites of quercetin after intestinal administration of quercetin-3-glucoside and its aglycone in rats.
Nakamura T; Kinjo C; Nakamura Y; Kato Y; Nishikawa M; Hamada M; Nakajima N; Ikushiro S; Murota K
Arch Biochem Biophys; 2018 May; 645():126-136. PubMed ID: 29574052
[TBL] [Abstract][Full Text] [Related]
19. Identification of Naringin Metabolites in Human Urine and Feces.
Zeng X; Bai Y; Peng W; Su W
Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):647-656. PubMed ID: 27744636
[TBL] [Abstract][Full Text] [Related]
20. Intestinal transport of quercetin glycosides in rats involves both deglycosylation and interaction with the hexose transport pathway.
Gee JM; DuPont MS; Day AJ; Plumb GW; Williamson G; Johnson IT
J Nutr; 2000 Nov; 130(11):2765-71. PubMed ID: 11053519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
